Startups

Associate Director or Director, Clinical Scientist

Kymera Therapeutics · Watertown, MA · On-site

← All jobs
About Kymera Therapeutics

Kymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.

About the role

Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics.

What they're looking for

  • Bachelor’s or advanced degree (MSc, PharmD, PhD) in Life Sciences or related field and 8+ years in pharmaceutical clinical drug development, with experience in global clinical trials and program execution
  • Experience in immunological diseases with an understanding of disease biology and treatment landscapes, Experience with clinical trials for dermatologic indications and endpoints is a plus
  • In-depth understanding of clinical development processes, regulatory requirements, and guidelines (FDA, EMEA, ICH, GCP)
  • Strong critical-thinking, problem-solving abilities and excellent medical writing skills
  • Maintain a patient-centric mentality throughout the drug development process
  • Kymera offers a competitive compensation package that recognizes both results and capabilities through market-based, performance-driven pay
More about this role

Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn .

  • PIONEER : We are courageous, resilient and rigorous in our mission to improve patients’ lives through our revolutionary degrader medicines.
  • COLLABORATE : We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine.
  • BELONG : We recognize our differences, inviting...

Read the full posting on Kymera Therapeutics's site ↗

Development

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.